IRIN examines “whether a new generation of social protection schemes, aimed at reducing poverty and often using cash transfers to the poorest, can be harnessed to bring down the rate of [tuberculosis (TB)] in developing countries.” The news service writes, “TB is a disease often associated with poverty because latent infections are more easily activated by malnutrition and lowered immune systems, and more quickly passed on in badly ventilated, overcrowded living conditions.”
Approximately 85,000 HIV-positive people in Burma, also known as Myanmar, are in need of antiretroviral treatment (ART) and cannot access it “due to a lack of funding, despite renewed international engagement with the government amid a wave of political reform, according to a report released Wednesday” by the medical aid group Medecins Sans Frontieres (MSF), the Associated Press/CBS News reports (2/22). “At the launch of a new report called ‘Lives in the Balance,’ MSF said that only a quarter of the estimated 120,000 people living with HIV and AIDS were receiving treatment, and that it was turning people away from its clinics,” BBC News writes. While plans were made last year among MSF and its partners to scale up treatment for HIV and tuberculosis (TB), “those proposals were shelved after the Global Fund” to Fight AIDS, Tuberculosis and Malaria cancelled its Round 11 grants, according to the news agency. “The money was expected to provide HIV drugs for 46,500 people in Myanmar, along with treatment for another 10,000 people sicken[ed] by drug-resistant tuberculosis in the country, [the report] said,” BBC writes (Fisher, 2/22).
CBS News examines the fight against tuberculosis (TB) in South Korea, which “has the highest incidence rate of tuberculosis among the world’s wealthiest countries, nations [that] belong to the 34-member Organization for Economic Cooperation and Development (OECD).” The news service continues, “In 2010, South Korea’s incidence rate of tuberculosis was 97 out of 100,000, according to the World Health Organization (WHO), while the mortality rate of TB was 5.4 out of 100,000. (In the U.S., the incidence rate was 4.1 and the mortality rate was 0.18 during the same time period.)”
“The Global Fund’s drive to ensure sustainability and efficiency means that it may not be able to meet its commitments to combat disease, says Laurie Garrett,” a senior fellow for global health at the Council on Foreign Relations, in Nature’s “World View” column. Citing his resignation letter, Garrett discusses the “the political struggle” that led Michel Kazatchkine to step down as executive director of the Global Fund to Fight AIDS, Tuberculosis and Malaria last week and writes, “It is a classic battle of titans, pitting urgency against long-term sustainability. … Kazatchkine essentially conceded victory to the forces for sustainability.”
“A pilot community program to improve [tuberculosis (TB)] detection in northern Tanzania has shown good results and could be replicated nationwide as the country seeks to improve its TB treatment and prevention systems,” IRIN reports. The program, run by Management Sciences for Health with help from PATH and Tanzania’s National Tuberculosis and Leprosy Programme and financial support from USAID, “emphasized that TB and HIV treatment must be done ‘hand in hand,'” according to IRIN.
In this post in the Center for Global Development’s (CGD) “Rethinking U.S. Foreign Assistance” blog, Connie Veillette, director of CGD’s rethinking U.S. foreign assistance initiative, highlights two recent posts by CGD’s Amanda Glassman and Nandini Oomman on the future of the Global Health Initiative (GHI). She writes, “With the Appropriations Committee weighing in by requiring a status report by mid-February on transitioning GHI to USAID, it is no understatement that the GHI is at an important juncture. Declining budgets for foreign assistance will also require new thinking on where the U.S. provides assistance and for what purpose” (1/31).
The Global Health Technologies Coalition (GHTC) — consisting of 40 global health research and advocacy organizations — on Tuesday held a congressional briefing to launch its third annual policy report, titled “Sustaining Progress: Creating U.S. policies to spur global health innovation,” GlobalPost’s “Global Pulse” blog reports (Donnelly, 2/28). The group is “warning deep cuts in the U.S. federal budget could reverse progress made on many diseases, including HIV/AIDS, tuberculosis and malaria,” VOA News writes (DeCapua, 2/28).
In an interview with Xinhua on Tuesday, Francis Adatu, head of the national leprosy and tuberculosis (TB) program in Uganda, warned that TB “remains a major public health problem” and that multidrug-resistant TB (MDR-TB) has emerged in the country, the news service writes. “‘According to our prevalence survey we found MDR-TB in 1.3 percent among new cases and 12.3 percent among people who have been exposed to drugs or treated over and over again,’ Adatu said,” Xinhua writes, noting that Adatu said treatment for MDR-TB was much more expensive than for drug-susceptible TB.
Two new reports from southern Africa’s Health Systems Trust show that pregnant women, infants, and people newly diagnosed with HIV infection are receiving more services, but the costs of care are increasing, PlusNews reports. The annual District Health Barometer shows that about half of infants born to HIV-positive mothers are being tested for the virus at six weeks; almost all pregnant women are tested for HIV, helping to lower the rate of mother-to-child HIV transmission to below four percent nationwide; and about 70 percent of people newly diagnosed with HIV receive screening for tuberculosis (TB), according to the news service.
According to a Pan American Health Organization (PAHO) and WHO joint press release, USAID “has tripled its financial support for the Pan American Health Organization/World Health Organization (PAHO/WHO) Regional Tuberculosis Program, which seeks to prevent 15,000 deaths from tuberculosis in Latin America and the Caribbean over the next five years and reduce the incidence of this disease.” The press release notes the commitment “increases a previous $5 million USAID/PAHO agreement, signed in November 2011 to strengthen programs for tuberculosis, maternal and neonatal health, and health systems in the region over the course of a three-year period, to a total of $8.9 million.” The press release states that $5.1 million is earmarked for the tuberculosis program, “up from an originally expected investment of $1.5 million” (10/31).